Abstract
Safety and Efficacy of Midostaurin in Combination with High-Dose Daunorubicin in 7+3 Induction for Acute Myeloid Leukemia with FLT3 Mutation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have